Analysis of Prognostic Factors After Yttrium-90 Radioembolization of Advanced Hepatocellular Carcinoma
- 1 August 2010
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 77 (5), 1441-1448
- https://doi.org/10.1016/j.ijrobp.2009.07.006
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Sorafenib in Advanced Hepatocellular CarcinomaThe New England Journal of Medicine, 2008
- Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosisHepatology, 2007
- Prospective Cohort Study of Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma in 8510 PatientsGastroenterology, 2006
- Management of hepatocellular carcinomaHepatology, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Yttrium-90 microspheres for the treatment of hepatocellular carcinomaGastroenterology, 2004
- Hepatic arterial90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: Interim safety and survival data on 65 patientsLiver Transplantation, 2004
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstructionCancer, 1997
- Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization.American Journal of Roentgenology, 1995